RADIOLABELED PEPTIDES FOR THE DIAGNOSIS AND TREATMENT OF BREAST AND PROSTATE TUMORS AND METASTASES OF SUCH TUMORS

摘要

Breast and/or prostate cancer is diagnosed and/or treated with a radiolabeled peptide or peptidomimetic that binds to GRP (Gastrin Releasing Peptide) receptors.